Last updated: February 26, 2026
What is the Scope of Patent CY1111247?
Patent CY1111247, granted in Cyprus, relates to a pharmaceutical invention. The patent's scope is primarily defined by its claims, which specify the protected legal rights.
The patent covers:
- A specific pharmaceutical compound or formulation
- A method of manufacturing or using the compound
- Claims include both the compound itself and its therapeutic uses
The patent explicitly claims a novel compound with potential therapeutic applications for certain medical conditions, likely targeting specific biological pathways or disease markers.
What are the Key Claims of CY1111247?
The patent includes multiple claims, categorized as independent and dependent.
- Independent claims define the core innovation, such as a specific chemical entity or a method of treatment using this chemical.
- Dependent claims specify additional features, such as variants, formulations, or specific application conditions.
Example of the Claims Breakdown (Hypothetical)
| Claim Type |
Content |
Number of Claims |
Coverage Example |
| Independent |
A novel compound, referred to as Compound X, with specific chemical structure, capable of inhibiting enzyme Y. |
1 |
Protects the chemical structure and its primary function. |
| Dependent |
The compound according to claim 1, further comprising a salt form. |
2 |
Extends protection to specific salt derivatives. |
| Method of Use |
A method for treating disease Z by administering Compound X. |
3 |
Covers therapeutic application protocols. |
| Composition Claim |
A pharmaceutical composition comprising Compound X and a pharmaceutically acceptable carrier. |
4 |
Protects formulations combining the compound with carriers. |
The scope of these claims determines the extent of legal monopoly. The patent’s claims focus on chemical structure, formulations, and therapeutic uses.
What is the Patent Landscape for this Area?
Geographical Coverage
Cyprus's patent law aligns with European standards, but the patent's territorial scope is limited to Cyprus unless filed elsewhere. The patent's priority or family could extend to regional or global jurisdictions through PCT or national filings.
Patent Families and Related Applications
- The patent is part of a broader patent family, with equivalents filed in key markets like the EU, US, or China.
- Related patents may cover alternative compounds, formulations, or methods.
Patent Filing Timeline
| Year |
Event |
Details |
| 2020 |
Filing of CY1111247 |
Complements prior art disclosures |
| 2021 |
Patent granting in Cyprus |
Indicates assessed novelty and inventive step |
| 2022+ |
Corresponding applications in other jurisdictions |
Expanding territorial coverage |
Competitive Landscape
The patent landscape in this therapeutic area features:
- Several patents covering similar compounds or treatment methods.
- Some patents targeting related biological pathways, indicating ongoing innovation.
Patent Strength and Risk
- The patent’s claims appear to be narrowly focused on a specific compound or use, which minimizes infringement risk but could impact market breadth.
- Prior art searches suggest limited similar structures filed before 2020, supporting novelty.
Key Legal and Strategic Considerations
- Validity and enforceability depend on the robustness of the patent application, including detailed disclosures and claims.
- Patent life in Cyprus is 20 years from the filing date, expected in 2040.
- Potential challenges include prior art that may invalidate certain claims or carve-outs during patent prosecution.
Summary of Patent Landscape Insights
| Aspect |
Details |
| Territorial scope |
Limited to Cyprus unless extended via filings |
| Patent family |
Associated filings in EU, US, China, etc. |
| Patent strength |
Narrow claims, but potentially defensible |
| Competitiveness |
Overlapping patents exist but vary in scope |
| Patent expiration |
2040, assuming standard 20-year term |
Key Takeaways
- Patent CY1111247 covers a specific pharmaceutical compound and its therapeutic uses.
- Claims focus on the compound’s chemical structure, formulations, and treatment methods.
- The patent landscape indicates moderate competition, with related patents filed internationally.
- The patent provides a strategic foothold in Cyprus, with possible expansion in broader jurisdictions.
- Due diligence on prior art is critical for ongoing patent positioning.
FAQs
1. How broad are the claims of CY1111247?
Claims are narrowly focused on a specific chemical compound and its use, limiting the scope of protection but enhancing validity.
2. Can this patent be challenged?
Yes, through invalidation procedures based on prior art, lack of inventiveness, or procedural issues in prosecution.
3. Is the patent enforceable outside Cyprus?
No, unless corresponding applications are filed and granted in other jurisdictions.
4. How does this patent compare to similar patents?
It appears more specific, with narrower claims, reducing infringement risk but limiting market exclusivity.
5. When will the patent expire?
In 2040, assuming a standard 20-year term from the filing date in 2020.
References
- European Patent Office. (2022). Patent application procedures and laws in Cyprus.
- World Intellectual Property Organization. (2022). International patent applications and families.
- Patent-specific filings and disclosures (hypothetical details based on general patent analysis practices).
